Share Issue/Capital Change • Apr 8, 2022
Share Issue/Capital Change
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 7939H
Empyrean Energy PLC
08 April 2022
Empyrean Energy Plc / Index: AIM / Epic: EME / Sector: Oil & Gas
Empyrean Energy plc
Exercise of Warrants
8 April 2022
Empyrean Energy ("Empyrean" or the "Company"), the oil and gas development company with interests in China, Indonesia and the United States, advises that it has received a notice to exercise warrants (exercise price 9p per Warrant) over a total of 511,111 Ordinary Shares (the "Warrant Shares"), for which funds of £45,999.99 have been received by the Company.
Application will be made for the admission of the Warrant Shares to trading on AIM ("Admission"). Admission is expected to take place on 14 April 2022. The Warrant Shares will rank pari passu with the existing ordinary shares on issue.
Following Admission, the Company's enlarged issued share capital will comprise 665,331,891 ordinary shares of 0.2p each (the "Shares"), each with voting rights. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, securities of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.
-ENDS-
For further information please contact the following:
| Empyrean Energy plc | |
| Tom Kelly | Tel: +61 6146 5325 |
| Cenkos Securities plc (Nominated Advisor and Broker) | |
| Neil McDonald | Tel: +44 (0) 131 220 9771 |
| Pete Lynch | Tel: +44 (0) 131 220 9772 |
| First Equity Limited (Joint Broker) | |
| Jason Robertson | Tel: +44 (0) 20 7330 1883 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
IOEEAPLPESLAEEA
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.